Dysentery Diagnosis and Treatment
For a patient presenting with dysentery (bloody diarrhea, fever, abdominal pain, tenesmus), obtain stool cultures for Salmonella, Shigella, Campylobacter, Yersinia, and Shiga toxin testing immediately, and initiate empiric antibiotics with azithromycin (or a fluoroquinolone based on local resistance patterns) only if the patient has documented fever in a medical setting with classic bacillary dysentery syndrome, is an infant <3 months old, or has recent international travel with fever ≥38.5°C. 1
Diagnostic Workup
Essential Clinical Features to Assess
- Fever documentation: Temperature ≥38.5°C measured in a medical setting is a key indicator for empiric antibiotic therapy in dysentery 1
- Stool characteristics: Frequent scant bloody stools with mucus, accompanied by tenesmus and abdominal cramps, suggest bacillary dysentery (typically Shigella) 1
- Volume depletion signs: Assess for tachycardia, orthostasis, decreased urination, lethargy, decreased skin turgor, and dry mucous membranes 1
- Travel history: Recent international travel within 3 days prior to symptom onset significantly alters management 1
- Immunocompromised status: HIV/AIDS, immunosuppressive medications, or other immune deficiencies require broader diagnostic evaluation 1
Mandatory Laboratory Testing
- Stool culture: Test for Salmonella, Shigella, Campylobacter, and Yersinia in all patients with fever, bloody stools, severe abdominal cramping, or signs of sepsis 1
- Shiga toxin testing: STEC O157 should be assessed by culture on sorbitol-MacConkey agar, and non-O157 STEC detected by Shiga toxin or genomic assays—this is critical because antibiotics are contraindicated if STEC is identified 1
- Blood cultures: Obtain from infants <3 months, patients with signs of septicemia, suspected enteric fever, or immunocompromised patients 1
- Fecal inflammatory markers: Presence of fecal leukocytes, lactoferrin, or occult blood supports bacterial etiology 1
Special Diagnostic Considerations
- Yersinia testing: Consider in patients with persistent right lower quadrant pain mimicking appendicitis, especially children with exposure to raw/undercooked pork 1
- C. difficile testing: Required if patient received antibiotics within the preceding 8-12 weeks 1
- Parasitic evaluation: Test for Entamoeba histolytica if symptoms persist ≥14 days or if patient is from an endemic region 1
Treatment Algorithm
Immediate Rehydration (All Patients)
- Reduced osmolarity oral rehydration solution (ORS) is the cornerstone of treatment for mild to moderate dehydration, regardless of etiology 1, 2
- Intravenous isotonic fluids (lactated Ringer's) for severe dehydration, shock, altered mental status, or inability to tolerate oral intake 1
- Nasogastric ORS administration may be considered in patients with moderate dehydration who cannot tolerate oral intake 1
Empiric Antibiotic Therapy: When to Treat
Treat empirically in these specific scenarios ONLY:
Infants <3 months of age with suspected bacterial etiology: Use third-generation cephalosporin 1, 2
Classic bacillary dysentery syndrome: Ill immunocompetent patients with documented fever in a medical setting, abdominal pain, bloody diarrhea, and tenesmus presumptively due to Shigella 1
Recent international travelers with temperature ≥38.5°C and/or signs of sepsis 1, 2
Immunocompromised patients with severe illness and bloody diarrhea 1
Suspected enteric fever with sepsis features: Treat empirically with broad-spectrum antibiotics after obtaining blood, stool, and urine cultures 1
Do NOT treat empirically in immunocompetent adults and children with bloody diarrhea while awaiting diagnostic results, except for the above scenarios 1
Antibiotic Selection
Adults: Azithromycin (preferred) or fluoroquinolone (ciprofloxacin), depending on local susceptibility patterns and travel history 1, 2
Children: Azithromycin based on local susceptibility patterns and travel history 1
Modify or discontinue antibiotics when a specific pathogen is identified from stool culture 1
Critical Contraindications
NEVER give antibiotics if STEC O157:H7 or other Shiga toxin 2-producing strains are suspected or confirmed—this significantly increases the risk of hemolytic uremic syndrome 1, 2, 3
- Patients with STEC typically present with bloody diarrhea but are NOT febrile at presentation 1
- Wait for Shiga toxin testing results before initiating antibiotics in bloody diarrhea without high fever 2, 3
Adjunctive Therapy
- Antimotility agents (loperamide): May be used in immunocompetent adults with adequate hydration, but NEVER in children <18 years or any patient with fever/bloody diarrhea 2
- Antiemetics (ondansetron): May facilitate oral rehydration in children >4 years 2
- Probiotics: May reduce symptom duration in immunocompetent patients 2
Reassessment and Follow-Up
- Clinical reevaluation is indicated if no improvement within 48-72 hours: Consider antibiotic resistance, inadequate rehydration, or noninfectious causes (inflammatory bowel disease, ischemic colitis) 1
- Persistent symptoms ≥14 days: Reassess for parasitic infections (Giardia, Entamoeba histolytica), inflammatory bowel disease, or postinfectious irritable bowel syndrome 1
- Follow-up stool testing: Generally not recommended after symptom resolution except when required by local health authorities for return to childcare or food-handling employment 1
Common Pitfalls to Avoid
- Empiric antibiotics without fever documentation: Most immunocompetent patients with bloody diarrhea do not require antibiotics while awaiting culture results 1
- Treating STEC with antibiotics: This increases hemolytic uremic syndrome risk—always obtain Shiga toxin testing before treating bloody diarrhea 1, 2, 3
- Neglecting rehydration: ORS is the priority intervention and reduces mortality more effectively than antibiotics alone 1, 2
- Treating asymptomatic contacts: Do not offer empiric antibiotics to contacts; advise infection control measures only 1